| Title | Date | PubMed ID |
|---|
| Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine. | 2016 Jul | 27128025 |
| Application of virtual screening to the discovery of novel nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with potential for the treatment of cancer and axonopathies. | 2016 Jun 15 | 27158141 |
| Identification of benzothiophene amides as potent inhibitors of human nicotinamide phosphoribosyltransferase. | 2016 Feb 1 | 26755394 |
| Analysis of the nicotinamide phosphoribosyltransferase family provides insight into vertebrate adaptation to different oxygen levels during the water-to-land transition. | 2015 Aug | 26012732 |
| Discovery and characterization of novel small-molecule inhibitors targeting nicotinamide phosphoribosyltransferase. | 2015 Jun 4 | 26040985 |
| Crystal structure of human nicotinic acid phosphoribosyltransferase. | 2015 | 26042198 |
| Retinal toxicity, in vivo and in vitro, associated with inhibition of nicotinamide phosphoribosyltransferase. | 2015 Mar | 25505128 |
| The function of nicotinamide phosphoribosyltransferase in the heart. | 2014 Nov | 25277684 |
| Nicotinamide phosphoribosyltransferase (NAMPT) activity is essential for survival of resting lymphocytes. | 2014 Feb | 24275857 |
| Discovery of potent and efficacious cyanoguanidine-containing nicotinamide phosphoribosyltransferase (Nampt) inhibitors. | 2014 Jan 1 | 24279990 |